Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / Lead Exposure Implicated in Rising Alzheimers Rates
Oncology Liquid biopsy Point of care testing Microscopy and imaging Research and Innovations Molecular Pathology

Lead Exposure Implicated in Rising Alzheimer's Rates

US study finds that patients with high bone lead levels are three times more likely to develop the disease

02/19/2026 News 2 min read

Share

Credit: Adobe Stock (Edited)

Higher cumulative lead exposure was associated with an increased risk of Alzheimer’s disease and all-cause dementia in a large, nationally representative US cohort, according to new research published in Alzheimer’s & Dementia.

The study analyzed data from the National Health and Nutrition Examination Survey (NHANES), linking baseline lead measurements to Medicare claims and National Death Index records for up to 30 years of follow-up. In the more recent NHANES cycles (1999 to 2016), individuals with the highest estimated patella bone lead levels had nearly three times the risk of developing Alzheimer’s disease and more than double the risk of all-cause dementia compared with those in the lowest exposure group.

Notably, blood lead levels – an indicator of recent exposure – were not associated with dementia risk. In contrast, estimated bone lead, which reflects cumulative exposure over decades, showed consistent associations with incident disease. Bone acts as a long-term reservoir for lead, releasing it gradually into circulation with age-related bone turnover. 

The findings serve as a stark environmental message; the authors estimated that if bone lead levels in the population were reduced to the 25th percentile, approximately 18 percent of new all-cause dementia cases might be prevented. This projected impact exceeds that of several established modifiable dementia risk factors identified in recent prevention frameworks.

Most adults in the study were born before 1980, when environmental lead exposure from gasoline, paint, and industrial sources was considerably higher. Although blood lead levels have declined nationally, cumulative body burden remains in bone for decades. The results suggest that historical exposure may continue to influence neurodegenerative disease risk in aging populations.

As dementia prevalence rises with population aging, these data position cumulative lead exposure as a potentially preventable contributor to neurodegenerative disease burden in the US.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

What’s New in Infectious Disease? (December 2021)
Point of care testing
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Resisting Resistance
Point of care testing
Resisting Resistance

October 21, 2016

1 min read

Rapid, affordable tests to spot bacterial infections could reduce antibiotic overprescription in resource-limited settings

HIV/AIDS: A Shifting Epidemic
Point of care testing
HIV/AIDS: A Shifting Epidemic

April 4, 2022

1 min read

HIV diagnoses in heterosexual people in the UK have overtaken those in gay and bisexual men

Career Snapshots with Bamidele Farinre
Point of care testing
Career Snapshots with Bamidele Farinre

April 20, 2022

3 min read

Michael Schubert interviews Bamidele Farinre about her work in mobile laboratory testing

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.